MUC16 Recombinant Antibody

$Western blot analysis of Human ovary cancer lysate. Using MUC16 (bsm-62912R) monoclonal antibody at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.\r\n$

Western blot analysis of Human ovary cancer lysate. Using MUC16 (bsm-62912R) monoclonal antibody at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.\r\n

Applications

WB
Flow-Cyt
ICC/IF

Reactivity

Human

Overview
Catalog #	bsm-62912r
Product Name	MUC16 Recombinant Antibody
Applications	WB, Flow-Cyt, ICC/IF
Reactivity	Human
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from human Mucin 16
Clonality	Recombinant
Isotype	IgG
Concentration	Lot dependent
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Storage Condition	Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	94025
Swiss Prot	Q8WXI7
Synonyms	Cancer antigen 125; CA125; CA125 ovarian cancer; MUC 16; Mucin16; Ovarian cancer related tumor marker CA125.
Background	Thought to provide a protective, lubricating barrier against particles and infectious agents at mucosal surfaces.
Application Dilution
WB	1:300-5000
Flow-Cyt	FCM1:20-100
ICC/IF	IFICC1:50-200